Our commitment to enabling early and accurate diagnosis of Rheumatoid Arthritis (RA) remains one of our top priorities, driven by innovative, high-quality diagnostic solutions designed to support better patient outcomes.
By offering a reliable and clinically validated anti-MCV assay, we support healthcare professionals in identifying RA with high specificity, enabling earlier intervention and improved patient management.
In this podcast, powered in partnership with Medlab Middle East, we explore the evolving landscape of autoimmune diagnostics and innovation, with a focus on anti-MCV as a key marker of RA.
Rheumatoid Arthritis
A holistic portfolio with Anti-MCV to unlock the full potential of early diagnosis.
Learn more about our unique technologies
This section contains information intended for wide distribution and may therefore contain product details or information that is not available or valid in your country.
Please contact your local Sebia representative. Information intended for healthcare professionals.
Carefully read the instructions in the reagent package inserts and instrument manuals.